Excess Mortality in Massachusetts During the Delta and Omicron Waves of COVID-19

Jeremy Samuel Faust; Chengan Du; Chenxue Liang; Katherine Dickerson Mayes; Benjamin Renton; Kristen Panthagani; Harlan M Krumholz

doi:10.1001/jama.2022.8045

Excess Mortality in Massachusetts During the Delta and Omicron Waves of COVID-19

JAMA. 2022 Jul 5;328(1):74-76. doi: 10.1001/jama.2022.8045.

Authors

Jeremy Samuel Faust¹, Chengan Du², Chenxue Liang², Katherine Dickerson Mayes³, Benjamin Renton⁴, Kristen Panthagani⁵, Harlan M Krumholz²

Affiliations

¹ Department of Emergency Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
² Center for Outcomes Research and Evaluation, Yale University School of Medicine, New Haven, Connecticut.
³ Harvard Affiliated Emergency Medicine Residency, Boston, Massachusetts.
⁴ Ariadne Labs, Brigham and Women's Hospital, Boston, Massachusetts.
⁵ Baylor College of Medicine, Houston, Texas.

Abstract

This modeling study estimates the excess deaths attributable to COVID-19 disease in Massachusetts during the Delta (June to December 2021) and Omicron (December 2021 to February 2022) waves.

MeSH terms

COVID-19* / epidemiology
COVID-19* / mortality
Hot Temperature
Humans
Massachusetts / epidemiology
Mortality
SARS-CoV-2*

Supplementary concepts

SARS-CoV-2 variants

Grants and funding

UL1 TR001863/TR/NCATS NIH HHS/United States